Compliance: Why Your Vendor’s Vendor is a Growth Risk
The core challenge for leadership is no longer merely managing direct vendors; it’s the cascading risk of the "nth-party" supplier.
The Illusion of Diversion Data: Why Confirmed Diversion Counts Misrepresent True Risk
Confirmed diversion cases do not equal true prevalence - they are directly dependent on investigative proficiency, tooling, and the bandwidth of the teams doing the work.
How Artera is Using Agentic AI to Humanize Patient Care
Artera President Tom McIntyre talks about the practical application of AI in healthcare.
When Innovation Outpaces Oversight: Lessons from IV Spas to AI
We should never wait for tragedies to force a conversation around clear governance and accountability. Oversight has to evolve alongside innovation to protect people before harm occurs.
The Delegation Dilemma: Why It’s Time for Health Plans to Rethink Vendor-Managed Utilization Management
As an industry, we need to ask hard questions. Are delegated vendors delivering on the promise of better, faster, more transparent decisions? Or are they simply moving the pain to another part of the system?
Protecting Your Biotech: Understanding the Risks of Compounded GLP-1s
With the global market for anti-obesity drugs projected to hit $95 billion by 2030, it’s no surprise that compounded semaglutide is gaining traction as a cheaper, more accessible option. But for all its appeal, this route comes with real risks: regulatory uncertainty, legal exposure, and major insurance hurdles.
“Here, There and Everywhere”: Vendor Risks in the Health Care Sector
As healthcare continues to become more and more dependent on third-party vendor services, provider and technology entities must remain focused on the risks that their vendors present.
The Mechanics of a More Connected Healthcare Ecosystem [Video]
Arbiter’s Anjali Jameson on hospital and payer alignment.
The Behavioral Health AI Boom Is Real. So Are the Risks
Behavioral health doesn’t need tech that replaces people. It needs technology that respects them, amplifying what clinicians do best and helping more people get the care they deserve.
Innovate or Stagnate: Overcoming Model Governance Challenges in Life Sciences
By treating model governance as a proactive, integral part of operations rather than a box to check after the fact, life sciences organizations can uphold compliance, better allocate their resources, and gain a competitive edge.
The Key to Solving Medication Errors is At The Intersection of Technology and Standards
By integrating industry standards into e-prescribing software, prescribing organizations can reduce errors to improve patient outcomes and lessen the burden of medication-related errors on healthcare systems. Here’s a look at the new National Council for Prescription Drug Programs (NCPDP) Sig Standard aimed at improving prescription accuracy.
Balancing Innovation and Risk in Healthtech
While new technologies may demonstrate clinical benefits in controlled settings, their true value is determined by how well they fit into existing healthcare workflows.
The New Blueprint: How Clever Care Health Plan is Scaling Its Member Experience [Video]
MedCity News was at the Vive conference and spoke with executives who shared their insights for the healthcare industry.
Corporate Compliance in the Era of TEFCA
A culture of compliance means truly valuing an adherence to industry standards, rather than looking at SOPs as a series of boxes that need to be checked in order to claim that requirements have been met.
Implementing Inclusivity: Putting Clinical Trial Equity Into Practice
In the realm of inclusivity and equity, planning early and engaging key stakeholders throughout the process makes it possible to make these changes while also safeguarding participants. How can researchers put clinical trial equity into practice?
Modernizing – and Securing – Hospital Technology Infrastructure
How to prioritize evolving your systems to operate like a modern data center
Is the Healthcare Industry Embracing Risk in Its Contracts?
As the healthcare industry slowly moves toward value-based care, healthcare companies are thinking about taking on risk. During a panel at MedCity News’ INVEST conference, healthcare leaders shared some key ideas about how the industry is embracing risk in its contracts.
Report: 22% of providers saw death rates spike following a ransomware attack
Ransomware attacks had an impact beyond mortality rates as well, with 71% of respondents saying that these cyberattacks drove up lengths of stay and 36% saying they led to an increase in clinical complications.